Good Clinical Practice (GCP)
Our highly experienced, trained and competent team of specialist GCP auditors has conducted thousands of audits in all therapeutic areas, according to international and national regulations, in over 100 countries. Continual positive client feedback is evidence of our professionalism and competency.
The conduct of GCP quality audits is becoming an increasingly challenging process, owing to the complexity of clinical trials and the location of investigator sites. Although the majority of sponsor organizations reside in Europe, the USA and Japan, their clinical trial sites are often located in Asia, Africa, South America, the Middle East and the Far East. Our experienced team is adept at dealing with the diverse cultures that they encounter.
Highly Experienced.
Professional.
Global Reach.
Featured Resources
For a deeper dive into the ICH E6(R3) guidelines, check out our latest expert insights.
Webinar
ADAMAS Consulting’s webinar, “GCP ICH E6 R3 Unveiled: Navigating the Evolving Roles of Sponsors and CROs,” provides invaluable insights into the evolving landscape of Good Clinical Practice (GCP) guidelines.
Case Study
Our latest case study highlights how ADAMAS Consulting supported a leading pharmaceutical company in proactively identifying high-risk sites during a global Phase III oncology trial—aligning with ICH E6 (R3) guidelines.
Guide
Our Views
ADAMAS PODCAST
A NOVEL VIRUS NEEDS A NOVEL APPROACH
Letaviah Thomas – Consultant – ADAMAS Consulting
We are focusing on new and innovative ideas on how to manage compliance during these challenging times. Our US Consultant Letaviah Thomas explains the ADAMAS approach. Regulatory Authorities have recently affirmed that GxP compliance and safety remain absolutely paramount even in the context of the COVID-19 pandemic. Given the extensive travel and other restrictions in place to control the spread of the virus, alternative approaches to routine regulatory oversight are needed.
Let's Start a Conversation